Sidong Huang

Sidong Huang

UNVERIFIED PROFILE

Are you Sidong Huang?   Register this Author

Register author
Sidong Huang

Sidong Huang

Publications by authors named "Sidong Huang"

Are you Sidong Huang?   Register this Author

24Publications

772Reads

11Profile Views

eIF4A Inhibitors Suppress Cell-Cycle Feedback Response and Acquired Resistance to CDK4/6 Inhibition in Cancer.

Mol Cancer Ther 2019 11 8;18(11):2158-2170. Epub 2019 Aug 8.

Department of Biochemistry, The Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-19-0162DOI Listing
November 2019

SWI/SNF-Compromised Cancers Are Susceptible to Bromodomain Inhibitors.

Cancer Res 2019 05 15;79(10):2761-2774. Epub 2019 Mar 15.

Departments of Oncology and Experimental Medicine, McGill University, Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-18-1545DOI Listing
May 2019

CRISPR/Cas9 Editing to Facilitate and Expand Drug Discovery.

Curr Gene Ther 2017 ;17(4):275-285

Department of Biochemistry, McGill University, Montreal, QC, H3G 1Y6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1566523217666171121164615DOI Listing
April 2019

The Human Adenovirus Type 5 E4orf4 Protein Targets Two Phosphatase Regulators of the Hippo Signaling Pathway.

J Virol 2015 Sep 17;89(17):8855-70. Epub 2015 Jun 17.

Department of Biochemistry, McGill University, Montreal, Québec, Canada The Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Québec, Canada Department of Oncology, McGill University, Montreal, Québec, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.03710-14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524087PMC
September 2015

Increased in vitro and in vivo sensitivity of BRCA2-associated pancreatic cancer to the poly(ADP-ribose) polymerase-1/2 inhibitor BMN 673.

Cancer Lett 2015 Aug 9;364(1):8-16. Epub 2015 Apr 9.

Rosalind and Morris Goodman Cancer Research Centre, McGill University, 1160 Pine Ave. West, Montreal, Quebec, Canada H3A 1A3; The Research Institute of the McGill University Health Centre, 1001 Decarie Boulevard, Montreal, Quebec, Canada H4A 3J1. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03043835150026
Publisher Site
http://dx.doi.org/10.1016/j.canlet.2015.04.003DOI Listing
August 2015

SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer.

Cell Res 2015 Apr 6;25(4):445-58. Epub 2015 Feb 6.

Department of Biochemistry, The Rosalind and Morris Goodman Cancer Centre, McGill University, Montreal, QC H3G 1Y6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/cr.2015.16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387553PMC
April 2015

Genetic and functional studies implicate synaptic overgrowth and ring gland cAMP/PKA signaling defects in the Drosophila melanogaster neurofibromatosis-1 growth deficiency.

PLoS Genet 2013 Nov 21;9(11):e1003958. Epub 2013 Nov 21.

Massachusetts General Hospital Center for Cancer Research and Harvard Medical School, Charlestown, Massachusetts, United States of America ; Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pgen.1003958DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836801PMC
November 2013

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.

Nature 2012 Jan 26;483(7387):100-3. Epub 2012 Jan 26.

Division of Molecular Carcinogenesis, Center for Biomedical Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature10868DOI Listing
January 2012

NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome.

Cell 2010 Jul;142(2):218-29

Divisions of Molecular Carcinogenesis and Molecular Genetics, Center for Biomedical Genetics and Cancer Genomics Center, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2010.06.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913027PMC
July 2010

ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome.

Cancer Cell 2009 Apr;15(4):328-40

Division of Molecular Carcinogenesis, Center for Biomedical Genetics and Cancer Genomics Center, The Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2009.02.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693316PMC
April 2009

A systematic high-throughput screen of a yeast deletion collection for mutants defective in PHO5 regulation.

Genetics 2005 Apr 3;169(4):1859-71. Epub 2005 Feb 3.

Department of Biochemistry and Biophysics, Howard Hughes Medical Institute, University of California, San Francisco, 94143-2240, USA.

View Article

Download full-text PDF

Source
http://www.genetics.org/content/genetics/169/4/1859.full.pdf
Web Search
http://www.genetics.org/cgi/doi/10.1534/genetics.104.038695
Publisher Site
http://dx.doi.org/10.1534/genetics.104.038695DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1360160PMC
April 2005